Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Kybella Clinical Development Timeline

Executive Summary

Chronicle of the development and review of Kythera's deoxycholic acid injection for submental fat.

Advertisement

Related Content

Chin Fat Not A 'Serious Condition' Worthy Of Priority Review, FDA Says
Patient-Reported Outcomes Data Earned Kybella A Claim For Emotional Impacts
Kythera Claims Kybella Name After Lundbeck Stumbles With Carbella
Kybella Approval Shows How To Work With FDA On Clinical Outcome Assessments
Kybella Reviewers

Topics

Advertisement
UsernamePublicRestriction

Register